This is an open-label positron emission tomography/computed tomography (PET/CT) study to
investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in prostate
cancer patients. A single dose of 111-148 Mega-Becquerel (MBq) 68Ga-NOTA-RM26 will be
injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT
images.
Phase:
Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)